ProfileGDS4284 / 206932_at
TitleChronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood
OrganismHomo sapiens


control 0.2 mg/kg 1 mg/kg 2 mg/kg 4 mg/kg 6 mg/kg pre-treatment 24 hrs 4 wks 24 hrs 4 wks 24 hrs 4 wks 4 hrs 24 hrs 4 wks 4 hrs 24 hrs 4 wks 401 402 403 404 411 422 424 425 427 428 441 443 444 448 449 450 451 452 401 402 411 402 411 422 403 424 427 403 424 427 428 449 450 425 428 443 444 449 450 425 428 443 449 450 404 448 451 452 404 441 448 451 452 451 452 GSM687644 GSM687648 GSM687653 GSM687658 GSM687663 GSM687668 GSM687673 GSM687678 GSM687683 GSM687688 GSM687695 GSM687699 GSM687704 GSM687707 GSM687712 GSM687719 GSM687724 GSM687728 GSM687646 GSM687649 GSM687665 GSM687651 GSM687667 GSM687670 GSM687671 GSM687654 GSM687675 GSM687685 GSM687656 GSM687677 GSM687687 GSM687692 GSM687716 GSM687722 GSM687680 GSM687690 GSM687700 GSM687705 GSM687714 GSM687721 GSM687682 GSM687694 GSM687702 GSM687718 GSM687723 GSM687661 GSM687710 GSM687726 GSM687730 GSM687660 GSM687697 GSM687709 GSM687725 GSM687729 GSM687727 GSM687731 26% 34% 44% 26% 26% 29% 42% 2% 36% 14% 22% 16% 48% 26% 41% 19% 4% 20% 28% 23% 4% 27% 9% 23% 40% 34% 5% 6% 21% 24% 5% 25% 37% 5% 31% 32% 28% 12% 35% 28% 26% 4% 31% 33% 29% 11% 12% 39% 13% 26% 41% 31% 41% 51% 37% 22% sort by dose sort by time sort by individual Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM687644Patient 401 control56.521326
GSM687648Patient 402 control95.543134
GSM687653Patient 403 control148.57144
GSM687658Patient 404 control62.900926
GSM687663Patient 411 control70.473426
GSM687668Patient 422 control71.483129
GSM687673Patient 424 control153.39242
GSM687678Patient 425 control6.43432
GSM687683Patient 427 control119.57536
GSM687688Patient 428 control23.255314
GSM687695Patient 441 control80.204722
GSM687699Patient 443 control34.521516
GSM687704Patient 444 control196.25148
GSM687707Patient 448 control76.311426
GSM687712Patient 449 control141.83641
GSM687719Patient 450 control46.303919
GSM687724Patient 451 control11.26724
GSM687728Patient 452 control44.156820
GSM687646Patient 401 treated 24h70.911528
GSM687649Patient 402 treated 24h44.364323
GSM687665Patient 411 treated 24h8.998084
GSM687651Patient 402 treated 4 weeks69.890727
GSM687667Patient 411 treated 4 weeks16.8599
GSM687670Patient 422 treated 24h51.15823
GSM687671Patient 422 treated 4 weeks127.94440
GSM687654Patient 403 treated 24h85.201534
GSM687675Patient 424 treated 24h12.26455
GSM687685Patient 427 treated 24h10.99616
GSM687656Patient 403 treated 4 weeks38.054321
GSM687677Patient 424 treated 4 weeks54.201724
GSM687687Patient 427 treated 4 weeks8.313325
GSM687692Patient 428 treated 4h57.60225
GSM687716Patient 449 treated 4h112.45437
GSM687722Patient 450 treated 4h12.39095
GSM687680Patient 425 treated 24h84.487331
GSM687690Patient 428 treated 24h84.371732
GSM687700Patient 443 treated 24h107.06328
GSM687705Patient 444 treated 24h19.155112
GSM687714Patient 449 treated 24h94.602935
GSM687721Patient 450 treated 24h86.250628
GSM687682Patient 425 treated 4 weeks61.277926
GSM687694Patient 428 treated 4 weeks7.622564
GSM687702Patient 443 treated 4 weeks90.918931
GSM687718Patient 449 treated 4 weeks95.542633
GSM687723Patient 450 treated 4 weeks81.629929
GSM687661Patient 404 treated 4h21.314711
GSM687710Patient 448 treated 4h19.88612
GSM687726Patient 451 treated 4h147.09139
GSM687730Patient 452 treated 4h54.261613
GSM687660Patient 404 treated 24h79.269126
GSM687697Patient 441 treated 24h189.48141
GSM687709Patient 448 treated 24h96.368931
GSM687725Patient 451 treated 24h168.88841
GSM687729Patient 452 treated 24h291.33251
GSM687727Patient 451 treated 4 weeks141.39237
GSM687731Patient 452 treated 4 weeks54.287622